Canaccord lowered the firm’s price target on Enovix (ENVX) to $15 from $21 and keeps a Buy rating on the shares. The firm said they remain firm in their conviction that Enovix is among a select few in the market possessing the foundational technology required to achieve a genuine paradigm shift in battery science.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX: